Precision BioSciences to Participate in Upcoming Jefferies Healthcare Conference

Rhea-AI Summary

Precision BioSciences, Inc. (NASDAQ: DTIL) announced its participation in the Jefferies Healthcare Conference from June 8-10, 2022. The in-person fireside chat will occur on June 9 at 4:00 PM ET at the New York Marriott Marquis. A live webcast of the event will be accessible on the company’s website, with an archived replay available for 30 days post-event. Precision BioSciences specializes in gene editing therapies using its proprietary ARCUS® platform, focusing on CAR T immunotherapy and gene editing candidates to treat genetic diseases.

DURHAM, N.C.--(BUSINESS WIRE)-- Precision BioSciences, Inc. (Nasdaq: DTIL) a clinical stage gene editing company developing ARCUS®-based ex vivo allogeneic CAR T and in vivo gene editing therapies, today announced that the Company will participate in the Jefferies Healthcare Conference taking place June 8-10, 2022.

Details for the in-person fireside chat are as follows:

Date: Thursday, June 9, 2022
Time: 4:00 PM ET
Location: New York Marriott Marquis

The fireside chat will be available via a live webcast accessible on Precision’s website in the Investors section under Events & Presentations: https://investor.precisionbiosciences.com/events-and-presentations. An archived replay will be available for approximately 30 days following the event.

About Precision BioSciences, Inc.

Precision BioSciences, Inc. is a clinical stage biotechnology company dedicated to improving life (DTIL) with its novel and proprietary ARCUS® genome editing platform. ARCUS is a highly precise and versatile genome editing platform that was designed with therapeutic safety, delivery, and control in mind. Using ARCUS, the Company’s pipeline consists of multiple ex vivo “off-the-shelf” CAR T immunotherapy clinical candidates and several in vivo gene editing candidates designed to cure genetic and infectious diseases where no adequate treatments exist. For more information about Precision BioSciences, please visit www.precisionbiosciences.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220603005129/en/

Investor Contact:

Mei Burris

Director, Investor Relations & Finance

Mei.burris@precisionbiosciences.com



Media Contact:

Maurissa Messier

Senior Director, Corporate Communications

Maurissa.Messier@precisionbiosciences.com

Source: Precision BioSciences, Inc.

FAQ

When is Precision BioSciences participating in the Jefferies Healthcare Conference?

Precision BioSciences will participate in the Jefferies Healthcare Conference from June 8-10, 2022.

What time is Precision BioSciences' fireside chat at the Jefferies Healthcare Conference?

The fireside chat is scheduled for June 9, 2022, at 4:00 PM ET.

Where will Precision BioSciences' fireside chat be held?

The fireside chat will be held at the New York Marriott Marquis.

How can I watch the Precision BioSciences fireside chat?

The fireside chat will be available via a live webcast on Precision BioSciences' website.

What is Precision BioSciences known for?

Precision BioSciences is known for its ARCUS® genome editing platform for developing CAR T therapies and gene editing solutions.

What is the stock symbol for Precision BioSciences?

The stock symbol for Precision BioSciences is DTIL.